Advertisement

Index by author

February 01, 1997; Volume 25,Issue 2

A

  1. Abbott, Frank S.

    1. A Comparative Investigation of 2-Propyl-4-Pentenoic Acid (4-ene VPA) and its α-Fluorinated Analogue: Phase II Metabolism and Pharmacokinetics
      Wei Tang and Frank S. Abbott
      Drug Metabolism and Disposition February 1997, 25 (2) 219-227;

  2. Åkesson, Bengt

    1. Major Metabolic Pathway for N-Methyl-2-Pyrrolidone in Humans
      Bengt Åkesson and Bo A. g. Jönsson
      Drug Metabolism and Disposition February 1997, 25 (2) 267-269;

  3. Amin, Shantu

    1. Comparative Metabolism of the Tobacco-Related Carcinogens Benzo[a]pyrene, 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone, 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanol, andN′-Nitrosonornicotine in Human Hepatic Microsomes
      Marianne E. Staretz, Sharon E. Murphy, Christopher J. Patten, Maria G. Nunes, Werner Koehl, Shantu Amin, Leeann A. Koenig, F. Peter Guengerich and Stephen S. Hecht
      Drug Metabolism and Disposition February 1997, 25 (2) 154-162;

  4. Anderson, Wayne

    1. Metabolism and Excretion of the Novel Antipsychotic Drug Ziprasidone in Rats after Oral Administration of a Mixture of14C- and 3H-Labeled Ziprasidone
      Chandra Prakash, Amin Kamel, Wayne Anderson and Harry Howard
      Drug Metabolism and Disposition February 1997, 25 (2) 206-218;

  5. Avery, Michael J.

    1. Disposition and Metabolism of Tenidap in the Rat
      Hassan G. Fouda, Michael J. Avery, Deepak Dalvie, Fred C. Falkner, Lawrence S. Melvin and Robert A. Ronfeld
      Drug Metabolism and Disposition February 1997, 25 (2) 140-148;

B

  1. Barakat, Mouhsine

    1. In Vivo, Ex Vivo, and In Vitro Effects ofl-NAME and l-Arginine on the Metabolism of Theophylline in the Rabbit
      Mouhsine Barakat, Ayman O. S. El-Kadi and Patrick Du Souich
      Drug Metabolism and Disposition February 1997, 25 (2) 191-195;

  2. Brennan, Mark D.

    1. Human NAD(P)H:Quinone Oxidoreductase Induction in Human Hepatoma Cells after Exposure to Industrial Acrylates, Phenolics, and Metals
      Edward J. Winner, Russell A. Prough and Mark D. Brennan
      Drug Metabolism and Disposition February 1997, 25 (2) 175-181;

C

  1. Chang, Mayland

    1. Metabolism of the Human Immunodeficiency Virus Type 1 Reverse Transcriptase Inhibitor Delavirdine in Rats
      Mayland Chang, Virendra K. Sood, Gracella J. Wilson, David A. Kloosterman, Phillip E. Sanders, Michael J. Hauer and Paul E. Fagerness
      Drug Metabolism and Disposition February 1997, 25 (2) 228-242;

  2. Collins, Jerry M.

    1. Selective Biotransformation of the Human Immunodeficiency Virus Protease Inhibitor Saquinavir by Human Small-Intestinal Cytochrome P4503A4
      Michael E. Fitzsimmons and Jerry M. Collins
      Drug Metabolism and Disposition February 1997, 25 (2) 256-266;

D

  1. Dalvie, Deepak

    1. Disposition and Metabolism of Tenidap in the Rat
      Hassan G. Fouda, Michael J. Avery, Deepak Dalvie, Fred C. Falkner, Lawrence S. Melvin and Robert A. Ronfeld
      Drug Metabolism and Disposition February 1997, 25 (2) 140-148;

  2. Datta, Kaushik

    1. Co-oxidative Metabolism of 4-Aminobiphenyl by Lipoxygenase from Soybean and Human Term Placenta
      Kaushik Datta, Paul M. Sherblom and Arun P. Kulkarni
      Drug Metabolism and Disposition February 1997, 25 (2) 196-105;

  3. Dickey, Kenneth M.

    1. Short-Term Oral 3-Hydroxypyridin-4-one Dosing Increases Aluminum Excretion and Partially Reverses Aluminum-Induced Toxicity in the Rabbit Independent of Chelator Lipophilicity
      Robert A. Yokel, Kathryn A. Meurer, Chuen B. Hong, Kenneth M. Dickey, Thomas L. Skinner and Andrea M. Fredenburg
      Drug Metabolism and Disposition February 1997, 25 (2) 182-190;

E

  1. El-Kadi, Ayman O. S.

    1. In Vivo, Ex Vivo, and In Vitro Effects ofl-NAME and l-Arginine on the Metabolism of Theophylline in the Rabbit
      Mouhsine Barakat, Ayman O. S. El-Kadi and Patrick Du Souich
      Drug Metabolism and Disposition February 1997, 25 (2) 191-195;

F

  1. Fagerness, Paul E.

    1. Metabolism of the Human Immunodeficiency Virus Type 1 Reverse Transcriptase Inhibitor Delavirdine in Rats
      Mayland Chang, Virendra K. Sood, Gracella J. Wilson, David A. Kloosterman, Phillip E. Sanders, Michael J. Hauer and Paul E. Fagerness
      Drug Metabolism and Disposition February 1997, 25 (2) 228-242;

  2. Falkner, Fred C.

    1. Disposition and Metabolism of Tenidap in the Rat
      Hassan G. Fouda, Michael J. Avery, Deepak Dalvie, Fred C. Falkner, Lawrence S. Melvin and Robert A. Ronfeld
      Drug Metabolism and Disposition February 1997, 25 (2) 140-148;

  3. Fitzsimmons, Michael E.

    1. Selective Biotransformation of the Human Immunodeficiency Virus Protease Inhibitor Saquinavir by Human Small-Intestinal Cytochrome P4503A4
      Michael E. Fitzsimmons and Jerry M. Collins
      Drug Metabolism and Disposition February 1997, 25 (2) 256-266;

  4. Fouda, Hassan G.

    1. Disposition and Metabolism of Tenidap in the Rat
      Hassan G. Fouda, Michael J. Avery, Deepak Dalvie, Fred C. Falkner, Lawrence S. Melvin and Robert A. Ronfeld
      Drug Metabolism and Disposition February 1997, 25 (2) 140-148;

  5. Fredenburg, Andrea M.

    1. Short-Term Oral 3-Hydroxypyridin-4-one Dosing Increases Aluminum Excretion and Partially Reverses Aluminum-Induced Toxicity in the Rabbit Independent of Chelator Lipophilicity
      Robert A. Yokel, Kathryn A. Meurer, Chuen B. Hong, Kenneth M. Dickey, Thomas L. Skinner and Andrea M. Fredenburg
      Drug Metabolism and Disposition February 1997, 25 (2) 182-190;

G

  1. Green, Mitchell D.

    1. Comparison of Stably Expressed Rat UGT1.1 and UGT2B1 in the Glucuronidation of Opioid Compounds
      Christopher D. King, Gladys R. Rios, Mitchell D. Green, Peter I. Mackenzie and Thomas R. Tephly
      Drug Metabolism and Disposition February 1997, 25 (2) 251-255;

  2. Guengerich, F. Peter

    1. Comparative Metabolism of the Tobacco-Related Carcinogens Benzo[a]pyrene, 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone, 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanol, andN′-Nitrosonornicotine in Human Hepatic Microsomes
      Marianne E. Staretz, Sharon E. Murphy, Christopher J. Patten, Maria G. Nunes, Werner Koehl, Shantu Amin, Leeann A. Koenig, F. Peter Guengerich and Stephen S. Hecht
      Drug Metabolism and Disposition February 1997, 25 (2) 154-162;
    2. Effects of Freezing, Thawing, and Storage of Human Liver Samples on the Microsomal Contents and Activities of Cytochrome P450 Enzymes
      Hiroshi Yamazaki, Kiyoshi Inoue, Connie G. Turvy, F. Peter Guengerich and Tsutomu Shimada
      Drug Metabolism and Disposition February 1997, 25 (2) 168-174;

H

  1. Hauer, Michael J.

    1. Metabolism of the Human Immunodeficiency Virus Type 1 Reverse Transcriptase Inhibitor Delavirdine in Rats
      Mayland Chang, Virendra K. Sood, Gracella J. Wilson, David A. Kloosterman, Phillip E. Sanders, Michael J. Hauer and Paul E. Fagerness
      Drug Metabolism and Disposition February 1997, 25 (2) 228-242;

  2. Hecht, Stephen S.

    1. Comparative Metabolism of the Tobacco-Related Carcinogens Benzo[a]pyrene, 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone, 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanol, andN′-Nitrosonornicotine in Human Hepatic Microsomes
      Marianne E. Staretz, Sharon E. Murphy, Christopher J. Patten, Maria G. Nunes, Werner Koehl, Shantu Amin, Leeann A. Koenig, F. Peter Guengerich and Stephen S. Hecht
      Drug Metabolism and Disposition February 1997, 25 (2) 154-162;

  3. Hollenberg, Paul F.

    1. Metabolic Inactivation of Cytochrome P4502B1 by Phencyclidine
      Uma Sharma, Elizabeth S. Roberts, Ute M. Kent, S. Michael Owens and Paul F. Hollenberg
      Drug Metabolism and Disposition February 1997, 25 (2) 243-250;

  4. Hong, Chuen B.

    1. Short-Term Oral 3-Hydroxypyridin-4-one Dosing Increases Aluminum Excretion and Partially Reverses Aluminum-Induced Toxicity in the Rabbit Independent of Chelator Lipophilicity
      Robert A. Yokel, Kathryn A. Meurer, Chuen B. Hong, Kenneth M. Dickey, Thomas L. Skinner and Andrea M. Fredenburg
      Drug Metabolism and Disposition February 1997, 25 (2) 182-190;

  5. Howard, Harry

    1. Metabolism and Excretion of the Novel Antipsychotic Drug Ziprasidone in Rats after Oral Administration of a Mixture of14C- and 3H-Labeled Ziprasidone
      Chandra Prakash, Amin Kamel, Wayne Anderson and Harry Howard
      Drug Metabolism and Disposition February 1997, 25 (2) 206-218;

I

  1. Ikeda, Kazumasa

    1. Lethal Drug Interactions of Sorivudine, a New Antiviral Drug, with Oral 5-Fluorouracil Prodrugs
      Haruhiro Okuda, Takahito Nishiyama, Kenichiro Ogura, Sekio Nagayama, Kazumasa Ikeda, Shuji Yamaguchi, Yoshimasa Nakamura, Yasuro Kawaguchi and Tadashi Watabe
      Drug Metabolism and Disposition February 1997, 25 (2) 270-273;

  2. Inoue, Kiyoshi

    1. Effects of Freezing, Thawing, and Storage of Human Liver Samples on the Microsomal Contents and Activities of Cytochrome P450 Enzymes
      Hiroshi Yamazaki, Kiyoshi Inoue, Connie G. Turvy, F. Peter Guengerich and Tsutomu Shimada
      Drug Metabolism and Disposition February 1997, 25 (2) 168-174;

  3. Ishii, Yuji

    1. Induction of Two UDP-Glucuronosyltransferase Isoforms Sensitive to Phenobarbital that are Involved in Morphine Glucuronidation
      Yuji Ishii, Atsuko Takami, Kazuoki Tsuruda, Akiko Kurogi, Hideyuki Yamada and Kazuta Oguri
      Drug Metabolism and Disposition February 1997, 25 (2) 163-167;

J

  1. Johnson, Eric F.

    1. Diazepam Metabolism by cDNA-Expressed Human 2C P450s
      Frank Jung, Toby H. Richardson, Judy L. Raucy and Eric F. Johnson
      Drug Metabolism and Disposition February 1997, 25 (2) 133-139;

  2. Jönsson, Bo A. g.

    1. Major Metabolic Pathway for N-Methyl-2-Pyrrolidone in Humans
      Bengt Åkesson and Bo A. g. Jönsson
      Drug Metabolism and Disposition February 1997, 25 (2) 267-269;

  3. Jung, Frank

    1. Diazepam Metabolism by cDNA-Expressed Human 2C P450s
      Frank Jung, Toby H. Richardson, Judy L. Raucy and Eric F. Johnson
      Drug Metabolism and Disposition February 1997, 25 (2) 133-139;

K

  1. Kamel, Amin

    1. Metabolism and Excretion of the Novel Antipsychotic Drug Ziprasidone in Rats after Oral Administration of a Mixture of14C- and 3H-Labeled Ziprasidone
      Chandra Prakash, Amin Kamel, Wayne Anderson and Harry Howard
      Drug Metabolism and Disposition February 1997, 25 (2) 206-218;

  2. Kanazu, Takushi

    1. Comparison of in Vitro Carnitine and Glycine Conjugation with Branched-Side Chain and Cyclic Side Chain Carboxylic Acids in Rats
      Takushi Kanazu and Toshiro Yamaguchi
      Drug Metabolism and Disposition February 1997, 25 (2) 149-153;

  3. Kawaguchi, Yasuro

    1. Lethal Drug Interactions of Sorivudine, a New Antiviral Drug, with Oral 5-Fluorouracil Prodrugs
      Haruhiro Okuda, Takahito Nishiyama, Kenichiro Ogura, Sekio Nagayama, Kazumasa Ikeda, Shuji Yamaguchi, Yoshimasa Nakamura, Yasuro Kawaguchi and Tadashi Watabe
      Drug Metabolism and Disposition February 1997, 25 (2) 270-273;

  4. Kent, Ute M.

    1. Metabolic Inactivation of Cytochrome P4502B1 by Phencyclidine
      Uma Sharma, Elizabeth S. Roberts, Ute M. Kent, S. Michael Owens and Paul F. Hollenberg
      Drug Metabolism and Disposition February 1997, 25 (2) 243-250;

  5. King, Christopher D.

    1. Comparison of Stably Expressed Rat UGT1.1 and UGT2B1 in the Glucuronidation of Opioid Compounds
      Christopher D. King, Gladys R. Rios, Mitchell D. Green, Peter I. Mackenzie and Thomas R. Tephly
      Drug Metabolism and Disposition February 1997, 25 (2) 251-255;

  6. Kloosterman, David A.

    1. Metabolism of the Human Immunodeficiency Virus Type 1 Reverse Transcriptase Inhibitor Delavirdine in Rats
      Mayland Chang, Virendra K. Sood, Gracella J. Wilson, David A. Kloosterman, Phillip E. Sanders, Michael J. Hauer and Paul E. Fagerness
      Drug Metabolism and Disposition February 1997, 25 (2) 228-242;

  7. Koehl, Werner

    1. Comparative Metabolism of the Tobacco-Related Carcinogens Benzo[a]pyrene, 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone, 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanol, andN′-Nitrosonornicotine in Human Hepatic Microsomes
      Marianne E. Staretz, Sharon E. Murphy, Christopher J. Patten, Maria G. Nunes, Werner Koehl, Shantu Amin, Leeann A. Koenig, F. Peter Guengerich and Stephen S. Hecht
      Drug Metabolism and Disposition February 1997, 25 (2) 154-162;

  8. Koenig, Leeann A.

    1. Comparative Metabolism of the Tobacco-Related Carcinogens Benzo[a]pyrene, 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone, 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanol, andN′-Nitrosonornicotine in Human Hepatic Microsomes
      Marianne E. Staretz, Sharon E. Murphy, Christopher J. Patten, Maria G. Nunes, Werner Koehl, Shantu Amin, Leeann A. Koenig, F. Peter Guengerich and Stephen S. Hecht
      Drug Metabolism and Disposition February 1997, 25 (2) 154-162;

  9. Kulkarni, Arun P.

    1. Co-oxidative Metabolism of 4-Aminobiphenyl by Lipoxygenase from Soybean and Human Term Placenta
      Kaushik Datta, Paul M. Sherblom and Arun P. Kulkarni
      Drug Metabolism and Disposition February 1997, 25 (2) 196-105;

  10. Kurogi, Akiko

    1. Induction of Two UDP-Glucuronosyltransferase Isoforms Sensitive to Phenobarbital that are Involved in Morphine Glucuronidation
      Yuji Ishii, Atsuko Takami, Kazuoki Tsuruda, Akiko Kurogi, Hideyuki Yamada and Kazuta Oguri
      Drug Metabolism and Disposition February 1997, 25 (2) 163-167;

M

  1. Mackenzie, Peter I.

    1. Comparison of Stably Expressed Rat UGT1.1 and UGT2B1 in the Glucuronidation of Opioid Compounds
      Christopher D. King, Gladys R. Rios, Mitchell D. Green, Peter I. Mackenzie and Thomas R. Tephly
      Drug Metabolism and Disposition February 1997, 25 (2) 251-255;

  2. Melvin, Lawrence S.

    1. Disposition and Metabolism of Tenidap in the Rat
      Hassan G. Fouda, Michael J. Avery, Deepak Dalvie, Fred C. Falkner, Lawrence S. Melvin and Robert A. Ronfeld
      Drug Metabolism and Disposition February 1997, 25 (2) 140-148;

  3. Meurer, Kathryn A.

    1. Short-Term Oral 3-Hydroxypyridin-4-one Dosing Increases Aluminum Excretion and Partially Reverses Aluminum-Induced Toxicity in the Rabbit Independent of Chelator Lipophilicity
      Robert A. Yokel, Kathryn A. Meurer, Chuen B. Hong, Kenneth M. Dickey, Thomas L. Skinner and Andrea M. Fredenburg
      Drug Metabolism and Disposition February 1997, 25 (2) 182-190;

  4. Murphy, Sharon E.

    1. Comparative Metabolism of the Tobacco-Related Carcinogens Benzo[a]pyrene, 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone, 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanol, andN′-Nitrosonornicotine in Human Hepatic Microsomes
      Marianne E. Staretz, Sharon E. Murphy, Christopher J. Patten, Maria G. Nunes, Werner Koehl, Shantu Amin, Leeann A. Koenig, F. Peter Guengerich and Stephen S. Hecht
      Drug Metabolism and Disposition February 1997, 25 (2) 154-162;

N

  1. Nagayama, Sekio

    1. Lethal Drug Interactions of Sorivudine, a New Antiviral Drug, with Oral 5-Fluorouracil Prodrugs
      Haruhiro Okuda, Takahito Nishiyama, Kenichiro Ogura, Sekio Nagayama, Kazumasa Ikeda, Shuji Yamaguchi, Yoshimasa Nakamura, Yasuro Kawaguchi and Tadashi Watabe
      Drug Metabolism and Disposition February 1997, 25 (2) 270-273;

  2. Nakamura, Yoshimasa

    1. Lethal Drug Interactions of Sorivudine, a New Antiviral Drug, with Oral 5-Fluorouracil Prodrugs
      Haruhiro Okuda, Takahito Nishiyama, Kenichiro Ogura, Sekio Nagayama, Kazumasa Ikeda, Shuji Yamaguchi, Yoshimasa Nakamura, Yasuro Kawaguchi and Tadashi Watabe
      Drug Metabolism and Disposition February 1997, 25 (2) 270-273;

  3. Nishiyama, Takahito

    1. Lethal Drug Interactions of Sorivudine, a New Antiviral Drug, with Oral 5-Fluorouracil Prodrugs
      Haruhiro Okuda, Takahito Nishiyama, Kenichiro Ogura, Sekio Nagayama, Kazumasa Ikeda, Shuji Yamaguchi, Yoshimasa Nakamura, Yasuro Kawaguchi and Tadashi Watabe
      Drug Metabolism and Disposition February 1997, 25 (2) 270-273;

  4. Nunes, Maria G.

    1. Comparative Metabolism of the Tobacco-Related Carcinogens Benzo[a]pyrene, 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone, 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanol, andN′-Nitrosonornicotine in Human Hepatic Microsomes
      Marianne E. Staretz, Sharon E. Murphy, Christopher J. Patten, Maria G. Nunes, Werner Koehl, Shantu Amin, Leeann A. Koenig, F. Peter Guengerich and Stephen S. Hecht
      Drug Metabolism and Disposition February 1997, 25 (2) 154-162;

O

  1. Ogura, Kenichiro

    1. Lethal Drug Interactions of Sorivudine, a New Antiviral Drug, with Oral 5-Fluorouracil Prodrugs
      Haruhiro Okuda, Takahito Nishiyama, Kenichiro Ogura, Sekio Nagayama, Kazumasa Ikeda, Shuji Yamaguchi, Yoshimasa Nakamura, Yasuro Kawaguchi and Tadashi Watabe
      Drug Metabolism and Disposition February 1997, 25 (2) 270-273;

  2. Oguri, Kazuta

    1. Induction of Two UDP-Glucuronosyltransferase Isoforms Sensitive to Phenobarbital that are Involved in Morphine Glucuronidation
      Yuji Ishii, Atsuko Takami, Kazuoki Tsuruda, Akiko Kurogi, Hideyuki Yamada and Kazuta Oguri
      Drug Metabolism and Disposition February 1997, 25 (2) 163-167;

  3. Okuda, Haruhiro

    1. Lethal Drug Interactions of Sorivudine, a New Antiviral Drug, with Oral 5-Fluorouracil Prodrugs
      Haruhiro Okuda, Takahito Nishiyama, Kenichiro Ogura, Sekio Nagayama, Kazumasa Ikeda, Shuji Yamaguchi, Yoshimasa Nakamura, Yasuro Kawaguchi and Tadashi Watabe
      Drug Metabolism and Disposition February 1997, 25 (2) 270-273;

  4. Owens, S. Michael

    1. Metabolic Inactivation of Cytochrome P4502B1 by Phencyclidine
      Uma Sharma, Elizabeth S. Roberts, Ute M. Kent, S. Michael Owens and Paul F. Hollenberg
      Drug Metabolism and Disposition February 1997, 25 (2) 243-250;

P

  1. Patten, Christopher J.

    1. Comparative Metabolism of the Tobacco-Related Carcinogens Benzo[a]pyrene, 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone, 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanol, andN′-Nitrosonornicotine in Human Hepatic Microsomes
      Marianne E. Staretz, Sharon E. Murphy, Christopher J. Patten, Maria G. Nunes, Werner Koehl, Shantu Amin, Leeann A. Koenig, F. Peter Guengerich and Stephen S. Hecht
      Drug Metabolism and Disposition February 1997, 25 (2) 154-162;

  2. Prakash, Chandra

    1. Metabolism and Excretion of the Novel Antipsychotic Drug Ziprasidone in Rats after Oral Administration of a Mixture of14C- and 3H-Labeled Ziprasidone
      Chandra Prakash, Amin Kamel, Wayne Anderson and Harry Howard
      Drug Metabolism and Disposition February 1997, 25 (2) 206-218;

  3. Prough, Russell A.

    1. Human NAD(P)H:Quinone Oxidoreductase Induction in Human Hepatoma Cells after Exposure to Industrial Acrylates, Phenolics, and Metals
      Edward J. Winner, Russell A. Prough and Mark D. Brennan
      Drug Metabolism and Disposition February 1997, 25 (2) 175-181;

R

  1. Raucy, Judy L.

    1. Diazepam Metabolism by cDNA-Expressed Human 2C P450s
      Frank Jung, Toby H. Richardson, Judy L. Raucy and Eric F. Johnson
      Drug Metabolism and Disposition February 1997, 25 (2) 133-139;

  2. Richardson, Toby H.

    1. Diazepam Metabolism by cDNA-Expressed Human 2C P450s
      Frank Jung, Toby H. Richardson, Judy L. Raucy and Eric F. Johnson
      Drug Metabolism and Disposition February 1997, 25 (2) 133-139;

  3. Rios, Gladys R.

    1. Comparison of Stably Expressed Rat UGT1.1 and UGT2B1 in the Glucuronidation of Opioid Compounds
      Christopher D. King, Gladys R. Rios, Mitchell D. Green, Peter I. Mackenzie and Thomas R. Tephly
      Drug Metabolism and Disposition February 1997, 25 (2) 251-255;

  4. Roberts, Elizabeth S.

    1. Metabolic Inactivation of Cytochrome P4502B1 by Phencyclidine
      Uma Sharma, Elizabeth S. Roberts, Ute M. Kent, S. Michael Owens and Paul F. Hollenberg
      Drug Metabolism and Disposition February 1997, 25 (2) 243-250;

  5. Ronfeld, Robert A.

    1. Disposition and Metabolism of Tenidap in the Rat
      Hassan G. Fouda, Michael J. Avery, Deepak Dalvie, Fred C. Falkner, Lawrence S. Melvin and Robert A. Ronfeld
      Drug Metabolism and Disposition February 1997, 25 (2) 140-148;

S

  1. Sanders, Phillip E.

    1. Metabolism of the Human Immunodeficiency Virus Type 1 Reverse Transcriptase Inhibitor Delavirdine in Rats
      Mayland Chang, Virendra K. Sood, Gracella J. Wilson, David A. Kloosterman, Phillip E. Sanders, Michael J. Hauer and Paul E. Fagerness
      Drug Metabolism and Disposition February 1997, 25 (2) 228-242;

  2. Sharma, Uma

    1. Metabolic Inactivation of Cytochrome P4502B1 by Phencyclidine
      Uma Sharma, Elizabeth S. Roberts, Ute M. Kent, S. Michael Owens and Paul F. Hollenberg
      Drug Metabolism and Disposition February 1997, 25 (2) 243-250;

  3. Sherblom, Paul M.

    1. Co-oxidative Metabolism of 4-Aminobiphenyl by Lipoxygenase from Soybean and Human Term Placenta
      Kaushik Datta, Paul M. Sherblom and Arun P. Kulkarni
      Drug Metabolism and Disposition February 1997, 25 (2) 196-105;

  4. Shimada, Tsutomu

    1. Effects of Freezing, Thawing, and Storage of Human Liver Samples on the Microsomal Contents and Activities of Cytochrome P450 Enzymes
      Hiroshi Yamazaki, Kiyoshi Inoue, Connie G. Turvy, F. Peter Guengerich and Tsutomu Shimada
      Drug Metabolism and Disposition February 1997, 25 (2) 168-174;

  5. Skinner, Thomas L.

    1. Short-Term Oral 3-Hydroxypyridin-4-one Dosing Increases Aluminum Excretion and Partially Reverses Aluminum-Induced Toxicity in the Rabbit Independent of Chelator Lipophilicity
      Robert A. Yokel, Kathryn A. Meurer, Chuen B. Hong, Kenneth M. Dickey, Thomas L. Skinner and Andrea M. Fredenburg
      Drug Metabolism and Disposition February 1997, 25 (2) 182-190;

  6. Sood, Virendra K.

    1. Metabolism of the Human Immunodeficiency Virus Type 1 Reverse Transcriptase Inhibitor Delavirdine in Rats
      Mayland Chang, Virendra K. Sood, Gracella J. Wilson, David A. Kloosterman, Phillip E. Sanders, Michael J. Hauer and Paul E. Fagerness
      Drug Metabolism and Disposition February 1997, 25 (2) 228-242;

  7. Souich, Patrick Du

    1. In Vivo, Ex Vivo, and In Vitro Effects ofl-NAME and l-Arginine on the Metabolism of Theophylline in the Rabbit
      Mouhsine Barakat, Ayman O. S. El-Kadi and Patrick Du Souich
      Drug Metabolism and Disposition February 1997, 25 (2) 191-195;

  8. Staretz, Marianne E.

    1. Comparative Metabolism of the Tobacco-Related Carcinogens Benzo[a]pyrene, 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone, 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanol, andN′-Nitrosonornicotine in Human Hepatic Microsomes
      Marianne E. Staretz, Sharon E. Murphy, Christopher J. Patten, Maria G. Nunes, Werner Koehl, Shantu Amin, Leeann A. Koenig, F. Peter Guengerich and Stephen S. Hecht
      Drug Metabolism and Disposition February 1997, 25 (2) 154-162;

T

  1. Takami, Atsuko

    1. Induction of Two UDP-Glucuronosyltransferase Isoforms Sensitive to Phenobarbital that are Involved in Morphine Glucuronidation
      Yuji Ishii, Atsuko Takami, Kazuoki Tsuruda, Akiko Kurogi, Hideyuki Yamada and Kazuta Oguri
      Drug Metabolism and Disposition February 1997, 25 (2) 163-167;

  2. Tang, Wei

    1. A Comparative Investigation of 2-Propyl-4-Pentenoic Acid (4-ene VPA) and its α-Fluorinated Analogue: Phase II Metabolism and Pharmacokinetics
      Wei Tang and Frank S. Abbott
      Drug Metabolism and Disposition February 1997, 25 (2) 219-227;

  3. Tephly, Thomas R.

    1. Comparison of Stably Expressed Rat UGT1.1 and UGT2B1 in the Glucuronidation of Opioid Compounds
      Christopher D. King, Gladys R. Rios, Mitchell D. Green, Peter I. Mackenzie and Thomas R. Tephly
      Drug Metabolism and Disposition February 1997, 25 (2) 251-255;

  4. Tsuruda, Kazuoki

    1. Induction of Two UDP-Glucuronosyltransferase Isoforms Sensitive to Phenobarbital that are Involved in Morphine Glucuronidation
      Yuji Ishii, Atsuko Takami, Kazuoki Tsuruda, Akiko Kurogi, Hideyuki Yamada and Kazuta Oguri
      Drug Metabolism and Disposition February 1997, 25 (2) 163-167;

  5. Turvy, Connie G.

    1. Effects of Freezing, Thawing, and Storage of Human Liver Samples on the Microsomal Contents and Activities of Cytochrome P450 Enzymes
      Hiroshi Yamazaki, Kiyoshi Inoue, Connie G. Turvy, F. Peter Guengerich and Tsutomu Shimada
      Drug Metabolism and Disposition February 1997, 25 (2) 168-174;

W

  1. Watabe, Tadashi

    1. Lethal Drug Interactions of Sorivudine, a New Antiviral Drug, with Oral 5-Fluorouracil Prodrugs
      Haruhiro Okuda, Takahito Nishiyama, Kenichiro Ogura, Sekio Nagayama, Kazumasa Ikeda, Shuji Yamaguchi, Yoshimasa Nakamura, Yasuro Kawaguchi and Tadashi Watabe
      Drug Metabolism and Disposition February 1997, 25 (2) 270-273;

  2. Wilson, Gracella J.

    1. Metabolism of the Human Immunodeficiency Virus Type 1 Reverse Transcriptase Inhibitor Delavirdine in Rats
      Mayland Chang, Virendra K. Sood, Gracella J. Wilson, David A. Kloosterman, Phillip E. Sanders, Michael J. Hauer and Paul E. Fagerness
      Drug Metabolism and Disposition February 1997, 25 (2) 228-242;

  3. Winner, Edward J.

    1. Human NAD(P)H:Quinone Oxidoreductase Induction in Human Hepatoma Cells after Exposure to Industrial Acrylates, Phenolics, and Metals
      Edward J. Winner, Russell A. Prough and Mark D. Brennan
      Drug Metabolism and Disposition February 1997, 25 (2) 175-181;

Y

  1. Yamada, Hideyuki

    1. Induction of Two UDP-Glucuronosyltransferase Isoforms Sensitive to Phenobarbital that are Involved in Morphine Glucuronidation
      Yuji Ishii, Atsuko Takami, Kazuoki Tsuruda, Akiko Kurogi, Hideyuki Yamada and Kazuta Oguri
      Drug Metabolism and Disposition February 1997, 25 (2) 163-167;

  2. Yamaguchi, Shuji

    1. Lethal Drug Interactions of Sorivudine, a New Antiviral Drug, with Oral 5-Fluorouracil Prodrugs
      Haruhiro Okuda, Takahito Nishiyama, Kenichiro Ogura, Sekio Nagayama, Kazumasa Ikeda, Shuji Yamaguchi, Yoshimasa Nakamura, Yasuro Kawaguchi and Tadashi Watabe
      Drug Metabolism and Disposition February 1997, 25 (2) 270-273;

  3. Yamaguchi, Toshiro

    1. Comparison of in Vitro Carnitine and Glycine Conjugation with Branched-Side Chain and Cyclic Side Chain Carboxylic Acids in Rats
      Takushi Kanazu and Toshiro Yamaguchi
      Drug Metabolism and Disposition February 1997, 25 (2) 149-153;

  4. Yamazaki, Hiroshi

    1. Effects of Freezing, Thawing, and Storage of Human Liver Samples on the Microsomal Contents and Activities of Cytochrome P450 Enzymes
      Hiroshi Yamazaki, Kiyoshi Inoue, Connie G. Turvy, F. Peter Guengerich and Tsutomu Shimada
      Drug Metabolism and Disposition February 1997, 25 (2) 168-174;

  5. Yokel, Robert A.

    1. Short-Term Oral 3-Hydroxypyridin-4-one Dosing Increases Aluminum Excretion and Partially Reverses Aluminum-Induced Toxicity in the Rabbit Independent of Chelator Lipophilicity
      Robert A. Yokel, Kathryn A. Meurer, Chuen B. Hong, Kenneth M. Dickey, Thomas L. Skinner and Andrea M. Fredenburg
      Drug Metabolism and Disposition February 1997, 25 (2) 182-190;
Back to top

In this issue

Drug Metabolism and Disposition
Vol. 25, Issue 2
1 Feb 1997
Sign up for alerts